Expert US stock fundamental screening criteria and quality metrics to identify companies with durable competitive advantages and sustainable business models. Our fundamental analysis goes beyond simple ratios to understand the true drivers of long-term business value and profitability. We provide quality scores, economic moat analysis, and competitive positioning tools for comprehensive evaluation. Find quality companies with our comprehensive fundamental screening and expert analysis for long-term investment success.
Illumina Inc., the global leader in genomic sequencing technology, released first-quarter 2026 financial results on May 1, 2026, that outperformed consensus earnings and revenue estimates, paired with a material upward revision to full-year 2026 guidance. Shares of ILMN rose 5.3% immediately followi
Illumina Inc. (ILMN) - Q1 2026 Earnings Beat, Margin Expansion and Upward Full-Year Guidance Drive Share Gains - Margin Expansion
ILMN - Stock Analysis
4709 Comments
809 Likes
1
Juwairiyah
New Visitor
2 hours ago
Too late… oh well.
👍 279
Reply
2
Zaraiyah
Consistent User
5 hours ago
Every aspect is handled superbly.
👍 263
Reply
3
Diaja
Expert Member
1 day ago
Ah, what a pity I missed this.
👍 242
Reply
4
Khilani
Active Contributor
1 day ago
Expert US stock short interest and short squeeze potential analysis for identifying high-risk high-reward opportunities. Our short interest data helps you understand bearish sentiment and potential catalysts for short covering rallies.
👍 64
Reply
5
Suyapa
Registered User
2 days ago
I feel like applauding for a week straight. 👏
👍 230
Reply
© 2026 Market Analysis. All data is for informational purposes only.